• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Predicting Bitcoin Prices in 2025: Growth Potential and Influencing Factors

user avatar

by Giorgi Kostiuk

a year ago


Crypto firm Blockware has presented Bitcoin price forecasts for 2025, which vary depending on macroeconomic conditions and strategic decisions.

Bitcoin Price Variability in 2025

Blockware's forecast suggests Bitcoin's price could rise by 58%, reaching $150,000 in 2025. This might occur if Donald Trump does not proceed with a strategic Bitcoin reserve plan, and the Federal Reserve reverses its interest rate policies. Additionally, the behavior of long-term Bitcoin holders will be crucial.

US Government's Necessity to Stockpile BTC

To achieve $400,000, according to Blockware, the US government must not only convert its current holdings into a strategic Bitcoin reserve but also actively stockpile more Bitcoin. However, research group Galaxy Digital finds this unlikely, stating that while the US might not purchase Bitcoin in 2025, discussions on reserve policy will continue.

Factors That Could Contribute to Significant Price Growth

In the 'bull case' scenario of a $400,000 price, the Federal Reserve would need to adopt a more dovish policy. Also, major corporations like Alphabet or Amazon would need to incorporate Bitcoin into their financial strategies. Despite Microsoft's recent shareholder vote against this, accelerated adoption by the corporate sector is still seen as a potential growth driver.

Blockware highlights several scenarios that could critically impact Bitcoin's price by 2025, primarily macroeconomic policies, investor behavior, and strategies of large companies.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Converge Bio's AI Platform Aims to Transform Drug Development

chest

Converge Bio is leveraging its newly acquired $25 million funding to enhance its AI platform, which focuses on drastically reducing the time and costs associated with drug development.

user avatarKenji Takahashi

Converge Bio Secures $25 Million Series A Funding to Transform Drug Discovery

chest

Converge Bio, a startup based in Boston and Tel Aviv, has raised $25 million in Series A funding to enhance AI-driven drug discovery.

user avatarMaria Fernandez

Buterin Continues Charity Donations from Token Sales

chest

Vitalik Buterin continues his practice of selling unsolicited tokens and donating the proceeds to charity, emphasizing ethical considerations in cryptocurrency promotions.

user avatarRajesh Kumar

Vitalik Buterin Sells Unsolicited Tokens for 94 ETH

chest

Ethereum cofounder Vitalik Buterin has sold unsolicited tokens from his wallet, converting them into 94 ETH.

user avatarGustavo Mendoza

Grayscale Segments Crypto Market into Five Vertical Categories

chest

Grayscale has categorized its altcoin candidates into five verticals, reflecting a structured approach to the crypto market.

user avatarMiguel Rodriguez

Decline in FLOW Price Amid Controversial Asset Recovery

chest

The price of FLOW has seen a significant decline following the Flow project's controversial asset recovery actions.

user avatarLuis Flores

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.